Dr. Mohamed Aburawi is a Mid-Career MPA candidate at the Harvard Kennedy School, where he is a Center for Public Leadership Fellow and Edward S. Mason Fellow. He is also an MBA candidate at the MIT Sloan School of Management. In 2017 Mohamed founded Speetar, a telehealth platform awarded by Harvard and supported by MIT Sandbox. Launched in Libya, Speetar links under-served patients in post-conflict countries to a global pool of cultural and language-matched specialists. Speetar represents a disruptive healthcare model, breaking down economic, social, and geographic barriers that too often limit the options patients have when seeking quality medical care.
Prior to joining HKS, Mohamed worked at Harvard Medical School’s Center of Engineering in Medicine as a senior transplant surgery fellow where he led the design and development of a novel discarded human kidney reconditioning system, utilizing non-blood based ex-vivo organ perfusion (first in the USA); The cutting edge work he led is paving the way for a ground-breaking multi-center clinical trial supported by the New England Organ Bank.
In 2018, Mohamed was named one of the Bill and Melinda Gates Foundation GoalKeepers, and an Ashoka Visionary in recognition for his efforts leveraging digital technologies to enable healthcare delivery in low resource settings. In 2019 he was awarded the Harvard Medical School Dean’s Community Service Award. As a Cheng Fellow, Mohamed will continue to explore the importance of innovation at the intersection of technology, business, and healthcare, scaling up Speetar’s operations across Libya and throughout the Middle East and North Africa.